Ocugen (NASDAQ: OCGN) and Vaxart (NASDAQ: VXRT) stand out as two small companies hoping to achieve success. Vaxart's shares skyrocketed more than 1,500% in 2020, but Ocugen has been the bigger winner so far this year. Ocugen actually hasn't developed a COVID-19 vaccine candidate.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting